PRECICE 2 vs LON: which limb lengthening method is actually better?

PRECICE 2 is an internal magnetic intramedullary nail. A surgeon performs a controlled osteotomy on the femur or tibia, inserts the nail inside the bone, and the patient lengthens the leg one millimetre per day by holding an external remote against the skin — no pin sites, no visible hardware.

LON (Lengthening Over Nail) does the same osteotomy and inserts a similar internal nail, but adds an external fixator with 6–10 pins drilled through the skin into the bone. The external fixator does the actual daily distraction; the internal nail acts as the rail. Once the bone has lengthened to target, the external fixator comes off and the internal nail stays inside for the consolidation phase, then is removed at 12–18 months.

The headline differences sit in six data points pulled from the manufacturer specs, published case series (JBJS, JOSR), and the audited pricing of the 44 clinics in this directory. Read across one row at a time.

PRECICE 2 is the dominant method in the United States, Germany, the United Kingdom, the United Arab Emirates, Israel and Italy. In these markets, paying $80,000–$160,000 for the implant plus hospital plus surgeon fee is treated as the price of doing the surgery properly. The Paley Orthopedic & Spine Institute in West Palm Beach prices bilateral femur lengthening at about $104,500 and bilateral tibia at about $115,000. The Hospital for Special Surgery in New York and the Rubin Institute in Baltimore use PRECICE 2 as their default for cosmetic indications. The Paley European Institute in Warsaw and the Paley Middle East Clinic at Burjeel Medical City in Abu Dhabi follow the same protocol.

What patients pay for in these markets is not just the device. They pay for experienced, high-volume surgeons, hospital-grade complication-management protocols, US/EU regulatory oversight of the implant supply chain, and a level of medico-legal exposure that incentivises conservative practice. Across cosmetic-lengthening series the any-complication rate sits broadly in the 30–45% band, with serious (major) complications far rarer — in the low single-to-mid teens percent — and the pin-site burden LON adds is the main reason its total tends to run above an internal-nail series. That margin is part of what the price difference is buying.

LON is the dominant method in Turkey, Iran, India and Egypt because it gives a comparable height gain at roughly one-third of the price. Istanbul clinics state international LON package prices broadly in the low-to-mid $20,000s up to the mid-$40,000s, depending on bilateral versus staged structure: for example Wanna Be Taller (Assoc. Prof. Dr. Yunus Öç), LiveLifeTaller (Dr. Halil Buldu) at Acıbadem International, Prof. Dr. Yüksel Yurttaş, and AFA Limb Lengthening (Prof. Dr. Mustafa Uysal), the last of which also states a Quadrilateral LON variant for larger gains. Treat any specific figure as a starting point to confirm directly, since clinic pricing changes.

The cost difference is real, but it is not free. LON adds an external fixator phase. For 8–10 weeks during distraction the patient lives with 6–10 pins protruding through the thigh skin. Pin-site infection rates run 10–30% in published series — typically mild and treatable with oral antibiotics, but a daily reality. The fixator is removed once distraction is complete, and the internal nail handles the rest of consolidation. Final recovery looks essentially the same as PRECICE: a small scar at the hip and another at the knee, plus the now-faded pin marks distributed along the lateral thigh.

Every patient researching limb lengthening is running the same internal calculation, whether they articulate it or not. They are deciding how much physical discomfort during the 8–10 week distraction phase, plus how much social cost from visible external hardware during those weeks, they are willing to accept in exchange for a $50,000–$100,000 cost reduction.

The answer changes depending on whether the patient is paying out-of-pocket from savings (they tend toward LON), out-of-pocket from a loan (they tend toward LON, because the loan plus PRECICE compounds the financial stress), or out-of-pocket from comfortable disposable income (they tend toward PRECICE 2). It also changes with social context. A patient who works from home and lives alone can tolerate the external fixator more easily than a patient who has to commute to a corporate job during distraction. Surgeons in both markets see this calculation made in their consultation rooms every week.

Published complication data suggests method matters less than the surgeon's experience and case volume. Internal nails performed by a low-volume surgeon can carry complication rates closer to LON, while LON in the hands of a high-volume surgeon can carry rates closer to PRECICE 2. The peer-reviewed evidence is consistent in direction: experience compresses the gap.

That is why a sensible patient question is not "which method?" but "how many of these does the surgeon do, and what are their published outcomes?" Dr. Yunus Öç and Dr. Yüksel Yurttaş both run established, high-volume, multi-method Istanbul practices. Dr. Dror Paley has performed limb lengthening since the 1980s and trained many of the second-generation surgeons; the Paley team led the first US PRECICE Max surgery in December 2023. Surgeon experience is what buys down complication risk — the implant brand is a smaller factor than the marketing implies.

See our safety guide for the surgeon-volume data and how to ask a clinic about its actual published outcomes.

These five questions separate patients who choose the right method from patients who later regret the choice they made.

1. Can I genuinely absorb the higher price, or am I stretching? If you are stretching for PRECICE 2, the surgery cost will not be the last unexpected expense. Hidden costs (implant removal at 12–18 months, follow-up imaging, physiotherapy, complication treatment) add $5,000–$15,000 in either method.

2. Can I tolerate visible external hardware for 8–10 weeks? Patients who live alone, work from home, or are taking sabbatical time tolerate the LON external fixator easily. Patients who have to keep up appearances socially or professionally tend to find it harder than they expected.

3. How many of these cases does my surgeon actually do, and how consistently? A low-volume surgeon should narrow your choice regardless of which implant they prefer; a genuinely high-volume, experienced surgeon matters more to your outcome than the method label itself.

4. How important is the scar pattern in 5 years? At 24-month review, internal-nail scars are typically two faded marks of 1–3 cm. LON pin-site marks are typically 6–10 small puncture scars per leg, still visible but flattened.

5. Am I optimising for shortest recovery or lowest total cost? PRECICE 2 recovers 3–4 months faster in published series. LON costs $50,000–$100,000 less. Both are large numbers.

Patients who chose PRECICE 2 most often cite three reasons: the absence of visible external hardware during distraction, the reported faster return to full weight-bearing, and the lower complication rate in published series. They almost never cite the implant brand as such — they cite what the implant enables.

Patients who chose LON most often cite two reasons: cost (almost always the leading reason) and the surgeon, not the method. Patients tend to choose Dr. Öç, Dr. Buldu, Dr. Yurttaş or Dr. Uysal first, and accept LON as part of the package because LON is what the surgeon does. The reverse — choosing the method and then finding a surgeon — is rare in the Turkish market because PRECICE 2 packages in Istanbul are typically $35,000–$60,000 (still cheaper than the US but not by enough to change the value calculus for most patients).

The single category of regret we see in both methods is patients who rushed the timeline — returned to running, impact sports or heavy lifting inside 9 months — and refractured. That risk is method-independent and surgeon-independent. It is biology.

Reduced to its core, the PRECICE 2 vs LON decision comes down to this. If money is not the binding constraint, PRECICE 2 is the better cosmetic limb lengthening method on every published clinical metric: lower complication rate, faster recovery, smaller scars, no pin-site care.

If money is the binding constraint, LON closes most of the clinical gap when performed by a high-volume surgeon, and the savings ($50,000–$100,000) often free up enough capital for the post-op essentials patients underestimate (apartment with a walk-in shower, household help during distraction, full physiotherapy package, contingency for complication treatment).

The wrong question is "which method is better?" The right question is "which surgeon do I trust, and which method does that surgeon do enough of to be excellent at?" Side-by-side on cost, recovery and complication rates, see our detailed comparison page.